Paper Details 
Original Abstract of the Article :
Loxapine succinate, a newly developed neuroleptic drug, was administered to two groups of geropsychiatric patients: (a) 12 with psychosis and organic brain syndrome, and (b) 14 with chronic schizophrenia. After a two-week baseline period, loxapine was given for 12 weeks. The moderate therapeutic eff...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1111/j.1532-5415.1978.tb02400.x

データ提供:米国国立医学図書館(NLM)

Loxapine Succinate: A Neuroleptic Agent for Elderly Psychiatric Patients

This study delves into the fascinating world of geriatric psychiatry, specifically exploring the effectiveness of loxapine succinate, a neuroleptic drug, in treating elderly patients with psychosis and schizophrenia. This research uses a classic approach: a controlled clinical trial. The researchers administered loxapine to two groups of elderly patients: those with psychosis and organic brain syndrome, and those with chronic schizophrenia. The results, my dear colleagues, are quite intriguing. The study found that loxapine had a moderate therapeutic effect in patients who responded to the treatment, comparable to other neuroleptic drugs. The therapeutic dosage range, however, was significantly lower for elderly patients, about half that used for younger individuals. This discovery is quite important, as it highlights the need to adjust dosage based on age and individual needs. The study also identified some common side effects, such as drowsiness, mild extrapyramidal symptoms, and a slight increase in blood pressure. This is a vital piece of information for clinicians when prescribing loxapine to elderly patients.

Dosage Adjustment is Key for Elderly Patients

The study's finding that a lower dosage of loxapine is effective for elderly patients is quite remarkable. This implies that the drug's metabolism and effects are altered in older individuals. This is a prime example of how age can significantly impact drug efficacy and safety. This underscores the importance of personalized medicine and the need to adjust treatment regimens based on individual patient characteristics, including age.

Potential Benefits and Risks for Elderly Patients

Loxapine succinate offers potential benefits in managing psychiatric disorders in elderly patients. It is a valuable tool for clinicians treating these conditions. However, it is important to be aware of potential side effects, such as drowsiness, mild extrapyramidal symptoms, and a slight increase in blood pressure. These side effects may be more pronounced in older individuals. It's crucial for healthcare providers to carefully monitor patients and adjust dosages accordingly to maximize benefits and minimize risks.

Dr.Camel's Conclusion

This study reminds us that the desert of geriatric medicine is vast and complex. Just as a camel adapts to the arid conditions, we must adapt our treatment approaches to the unique needs of elderly patients. Dosage adjustments, careful monitoring, and an understanding of potential side effects are all crucial to providing safe and effective care for our older patients.

Date :
  1. Date Completed 1978-08-28
  2. Date Revised 2019-07-09
Further Info :

Pubmed ID

757995

DOI: Digital Object Identifier

10.1111/j.1532-5415.1978.tb02400.x

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.